| Literature DB >> 34169036 |
Mohammad Karim Saberi1, Arezoo Farhadi1, Samira Karami1, Heidar Mokhtari2.
Abstract
Background: COVID-19 pandemic crisis motivated researchers worldwide to deeply investigate it from different perspectives. As Iran is one of the highly-affected countries by Covid-19, Iranian researchers have focused on studying it. This study aimed at analyzing and visualizing Iranian researchers' papers on COVID-19 from a bibliometric perspective.Entities:
Keywords: Bibliometrics; COVID-19; Data visualization; Iran; SARS-CoV-2
Year: 2021 PMID: 34169036 PMCID: PMC8214034 DOI: 10.47176/mjiri.35.24
Source DB: PubMed Journal: Med J Islam Repub Iran ISSN: 1016-1430
Top Journals Publishing Iranian Researchers' Papers on COVID-19
| No. | Journal |
Documents | h-index 2019 | SNIP 2019 | SJR 2019 | Quartile | |
| n | % | ||||||
| 1 | Archives of Clinical Infectious Diseases | 13 | 3.21 | 11 | 0.454 | 0.236 | Q3 |
| 2 | Archives of Iranian Medicine | 12 | 2.96 | 45 | 0.713 | 0.472 | Q2 |
| 3 | Medical Hypotheses | 12 | 2.96 | 83 | 0.509 | 0.427 | Q3 |
| 4 | Infection Control and Hospital Epidemiology | 10 | 2.47 | 134 | 1.358 | 1.555 | Q1 |
| 5 | Multiple Sclerosis and Related Disorders | 9 | 2.22 | 30 | 1.014 | 0.829 | Q2 |
| 6 | Asian Journal of Psychiatry | 8 | 1.98 | 29 | 1.022 | 0.736 | Q2 |
| 7 | Archives of Medical Research | 5 | 1.23 | 76 | 0.76 | 0.755 | Q2 |
| 8 | Medical Journal of The Islamic Republic of Iran | 5 | 1.23 | 16 | 0.699 | 0.268 | Q3 |
| 9 | New Microbes and New Infections | 5 | 1.23 | 21 | 0.602 | 0.543 | Q3 |
| 10 | Science of The Total Environment | 5 | 1.23 | 224 | 1.977 | 1.661 | Q1 |
| 11 | Dermatologic Therapy | 4 | 0.99 | 63 | 0.883 | 0.583 | Q2 |
| 12 | International Immunopharmacology | 4 | 0.99 | 106 | 1.049 | 0.992 | Q1 |
| 13 | Iranian Journal of Medical Sciences | 4 | 0.99 | 23 | 1.025 | 0.447 | Q3 |
| 14 | Iranian Journal of Public Health | 4 | 0.99 | 31 | 0.742 | 0.318 | Q3 |
| 15 | Journal of Cellular Physiology | 4 | 0.99 | 167 | 1.186 | 1.267 | Q1 |
| 16 | Journal of Medical Virology | 4 | 0.99 | 111 | 0.78 | 0.855 | Q2 |
| 17 | Phytotherapy Research | 4 | 0.99 | 121 | 1.423 | 0.905 | Q2 |
| 18 | Academic Radiology | 3 | 0.74 | 92 | 1.075 | 0.954 | Q1 |
| 19 | Daru Journal of Pharmaceutical Sciences | 3 | 0.74 | 39 | 1.107 | 0.532 | Q2 |
| 20 | Diabetes and Metabolic Syndrome Clinical Research and Reviews | 3 | 0.74 | 29 | 0.982 | 0.672 | Q2 |
Top Iranian Institutions Highly Productive in Publishing Papers on COVID-19
| SCR* | Institution | Documents (N = 405) | Total Citation (rank) | Citations/Paper (rank) | h-index (rank) | |
| N | % | |||||
| 1st | Tehran University of Medical Sciences | 119 | 29.38 | 280 (2) | 2.35 (6) | 9 (2) |
| 2nd | Shahid Beheshti University of Medical Sciences | 77 | 19.01 | 292 (1) | 3.79 (3) | 10 (1) |
| 3rd | Iran University of Medical Sciences | 64 | 15.80 | 161 (4) | 2.52 (5) | 5 (4) |
| 4th | Shiraz University of Medical Sciences | 37 | 9.14 | 168 (3) | 4.54 (1) | 6 (3) |
| 5th | Tabriz University of Medical Sciences | 29 | 7.16 | 37 (8) | 1.28 (8) | 5 (4) |
| 6th | Baqiyatallah University of Medical Sciences | 26 | 6.42 | 46 (7) | 1.77 (7) | 3 (6) |
| 7th | Mashhad University of Medical Sciences | 22 | 5.43 | 25 (9) | 1.14 (9) | 3 (6) |
| 8th | Isfahan University of Medical Sciences | 18 | 4.44 | 18 (10) | 1.00 (10) | 3 (6) |
| 9th | National Research Institute of Tuberculosis and Lung Disease Tehran | 16 | 3.95 | 63 (5) | 3.94 (2) | 4 (5) |
| 10th | Children's Medical Center TUMS | 15 | 3.70 | 47 (6) | 3.13 (4) | 3 (6) |
Top Iranian Researchers Highly Productive in Publishing Papers on COVID-19
| Author's Name | No. of Articles | Total Citation (R) | Citations/Paper (Rank) | h-index (R) | Affiliation | Author ID |
| Rezaei, N | 12 | 46 | 3.83 (4) | 3 | Tehran University of Medical Sciences, Tehran, Iran | 57209784995 |
| Badrfam, R | 6 | 50 | 8.33 (2) | 2 | Tehran University of Medical Sciences, Tehran, Iran | 54994198100 |
| Haseli, S | 6 | 16 | 2.67 (6) | 2 | Shahid Beheshti University of Medical Sciences, Tehran, Iran | 57202386588 |
| Saffaei, A | 6 | 36 | 6.00 (3) | 1 | Shahid Beheshti University of Medical Sciences, Tehran, Iran | 56429617700 |
| Zandifar, A. | 6 | 50 | 8.33 (2) | 2 | Alborz University of Medical Sciences, Karaj, Iran | 57130779000 |
| Aminnejad, R | 5 | 10 | 2.00 (7) | 1 | Qom University of Medical Sciences, Qom, Iran | 56721304500 |
| Gholamrezanezhad, A | 5 | 4 | .80 (9) | 1 | Keck School of Medicine of USC, Los Angeles, United States | 10044363200 |
| Izadi, M | 5 | 5 | 1.00 (8) | 1 | Baqiyatallah University of Medical Sciences, Tehran, Iran | 16230256600 |
| Moradi, G | 5 | 3 | .60 (10) | 1 | Kurdistan University of Medical Sciences, Sanandaj, Iran | 48161434000 |
| Naser Moghadasi A. | 5 | 0 | .00 (11) | 0 | Tehran University of Medical Sciences, Tehran, Iran | 55362978300 |
| Sahraian | 5 | 0 | .00 (11) | 0 | Tehran University of Medical Sciences, Tehran, Iran | 55886074600 |
| Shalbafan, M | 5 | 10 | 2.00 (7) | 2 | Iran University of Medical Sciences, Tehran, Iran | 56641835000 |
| Tabarsi, P | 5 | 42 | 8.40 (1) | 1 | Shahid Beheshti University of Medical Sciences, Tehran, Iran | 22954831100 |
| Taheri, M. S | 5 | 19 | 3.80 (5) | 2 | Shahid Beheshti University of Medical Sciences, Tehran, Iran | 56186823500 |
| Talebi Bezmin Abadi, A | 5 | 5 | 1.00 (8) | 1 | Tarbiat Modares University, Tehran, Iran | 57194487001 |
Fig. 1Top Highly Cited Papers Published by Iranian Researches on COVID-19
| R | Authors | Title | Year | Source title | Cited by | Doc type |
| 1 | Aminian, A et al | COVID-19 Outbreak and Surgical Practice: Unexpected Fatality in Perioperative Period | 2020 | Annals of surgery | 55 | Article |
| 2 | Asadi-Pooya A A and Simani L. | Central nervous system manifestations of COVID-19: A systematic review | 2020 | Journal of the Neurological Sciences | 43 | Review |
| 2 | Zandifar A and Badrfam R | Iranian mental health during the COVID-19 epidemic | 2020 | Asian Journal of Psychiatry | 43 | Letter |
| 2 | Habibzadeh P and Stoneman E K | The novel coronavirus: A bird's eye view | 2020 | International Journal of Occupational and Environmental Medicine | 43 | Review |
| 2 | Malik Y S et al | Emerging novel coronavirus (2019-nCoV)—current scenario, evolutionary perspective based on genome analysis and recent developments | 2020 | Veterinary Quarterly | 43 | Article |
| 3 | Moein S T et al | Smell dysfunction: a biomarker for COVID-19 | 2020 | International Forum of Allergy and Rhinology | 41 | Article |
| 4 | Sahraei Z et al | Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine | 2020 | International Journal of Antimicrobial Agents | 35 | Article |
| 5 | Dhama K et al | COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics | 2020 | Human Vaccines and Immunotherapeutics | 31 | Review |
| 6 | Karimi-Zarchi M et al | Vertical Transmission of Coronavirus Disease 19 (COVID-19) from Infected Pregnant Mothers to Neonates: A Review | 2020 | Fetal and Pediatric Pathology | 26 | Review |
| 7 | Sharifi-Razavi, A Karimi N, and Rouhani N | COVID-19 and intracerebral haemorrhage: causative or coincidental? | 2020 | New Microbes and New Infections | 24 | Article |
| 8 | Farnoosh G et al | Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence - A narrative review | 2020 | Journal of Military Medicine | 22 | Review |
| 9 | Saghazadeh A, and Rezaei N. | Immune-epidemiological parameters of the novel coronavirus–a perspective | 2020 | Expert Review of Clinical Immunology | 21 | Article |
| 10 | Takian A, Raoofi A, and Kazempour-Ardebili S | COVID-19 battle during the toughest sanctions against Iran | 2020 | The Lancet | 20 | Letter |
Contribution of Middle Eastern Countries to COVID-19 Papers (n = 1362)
| No. | Country | Documents | % of Total | Rank |
| 1 | Iran | 405 | 29.74 | 1 |
| 2 | Turkey | 307 | 22.54 | 2 |
| 3 | Saudi Arabia | 179 | 13.14 | 3 |
| 4 | Israel | 128 | 9.40 | 4 |
| 5 | Egypt | 109 | 8.00 | 5 |
| 6 | United Arab Emirates | 51 | 3.74 | 6 |
| 7 | Iraq | 31 | 2.28 | 7 |
| 8 | Lebanon | 29 | 2.13 | 8 |
| 9 | Qatar | 29 | 2.13 | 8 |
| 10 | Jordan | 28 | 2.06 | 8 |
| 11 | Oman | 22 | 1.62 | 9 |
| 12 | Cyprus | 19 | 1.40 | 10 |
| 13 | Kuwait | 14 | 1.03 | 11 |
| 14 | Bahrain | 3 | 0.22 | 12 |
| 15 | Yemen | 3 | 0.22 | 12 |
| 16 | Palestine | 3 | 0.22 | 12 |
| 17 | Syrian Arab Republic | 2 | 0.15 | 13 |
Contribution of Middle Eastern Countries on Publishing Papers on COVID-19 (n = 1362)
| Rank | Country | Papers | % of the Total |
| 1 | United States | 4503 | 17.78 |
| 2 | China | 2998 | 11.84 |
| 3 | Italy | 2078 | 8.20 |
| 4 | United Kingdom | 1998 | 7.89 |
| 5 | India | 1093 | 4.32 |
| 6 | Canada | 767 | 3.03 |
| 7 | France | 753 | 2.97 |
| 8 | Germany | 716 | 2.83 |
| 9 | Australia | 657 | 2.59 |
| 10 | Spain | 646 | 2.55 |
| 11 | Switzerland | 425 | 1.68 |
| 12 | Brazil | 411 | 1.62 |
| 13 | Iran | 405 | 1.60 |
| 14 | Singapore | 355 | 1.40 |
| 15 | Netherlands | 347 | 1.37 |
| 16 | Turkey | 307 | 1.21 |
| 17 | Belgium | 264 | 1.04 |
| 18 | Hong Kong | 259 | 1.02 |
| 19 | Japan | 251 | 0.99 |
| 20 | South Korea | 235 | 0.93 |
Fig. 2
Fig. 3
Fig. 4